Keyword: Merck


Merck Germany Doubles HPAPI Potential

24.06.2022 -

The Life Science business segment of German pharmaceuticals, chemicals and life sciences group Merck has widened its US plant for high-potent active pharmaceutical...

Chemistry & Life Sciences

Proactive Supplier Risk Mitigation for Manufacturing and Testing Organizations

03.06.2022 -

There is a new urgency in the market for manufacturers and testing organizations to be prepared for rapid, unexpected changes in material resource access, exacerbated by...


Germany’s Merck Invests €440 million in Ireland

24.05.2022 -

The Life Science segment of Germany’s Merck is investing around €440 million to increase membrane and filtration manufacturing capabilities in Ireland’s County Cork. The...


Germany’s Merck to Expand Wuxi Production Site

04.05.2022 -

Germany’s Merck has signed has an agreement with the Administrative Management Committee of Wuxi National High-Tech Industrial Development Zone to “significantly expand”...


Curious2022 - Future Insight Conference

July 12 - 14, 2022 | Some of the world’s brightest scientists and most accomplished entrepreneurs come together to present their work and explore the future of science &...


Germany’s Merck Takes Lonza’s MAST Platform

06.04.2022 -

Germany’s Merck has acquired Lonza’s Modular Automated Sampling Technology (MAST) platform for an undisclosed sum. The Darmstadt-based chemicals, pharmaceuticals and life...


Germany’s Merck Closes Exelead Acquisition

24.02.2022 -

Germany’s Merck has completed the acquisition of US biopharmaceutical CDMO Exelead for $780 million in cash following the fulfillment of all closing conditions. The...


Germany’s Merck Restructures Life Science Segment

08.02.2022 -

German pharmaceuticals, chemicals and life sciences group Merck has restructured its life science business to promote growth and to better cater to the needs of an...